{"hands_on_practices": [{"introduction": "The defining feature of irreversible inhibition is the permanent loss of enzyme function. Unlike reversible inhibitors, these compounds effectively remove enzyme molecules from the active pool. This first exercise [@problem_id:2054780] provides a foundational understanding of this concept by asking you to quantify the amount of active enzyme remaining after stoichiometric inactivation, directly linking enzyme activity to the concentration of functional enzyme.", "problem": "In a research laboratory, a biochemist is studying a novel enzyme, 'catalysine,' which is crucial for a specific metabolic pathway. The total concentration of catalysine in a prepared sample is determined to be $20.0 \\text{ nM}$. The biochemist then introduces a newly synthesized compound, 'Inhibitor-X,' which is known to act as an irreversible inhibitor of catalysine by forming a stable covalent bond at its active site. After allowing the inhibition reaction to proceed to completion, an activity assay reveals that the overall catalytic activity of the enzyme in the sample has been reduced by $75.0\\%$.\n\nAssuming that the inhibitor binds stoichiometrically (one inhibitor molecule inactivates one enzyme molecule) and the reduction in activity is solely due to the inactivation of enzyme molecules, what is the effective concentration of the remaining active catalysine in the sample?\n\nExpress your answer in units of nanomolar (nM), rounded to three significant figures.", "solution": "Let the total enzyme concentration be $[E]_{\\text{tot}} = 20.0 \\text{ nM}$. For an irreversible, stoichiometric inhibitor where one inhibitor molecule inactivates one enzyme molecule, the catalytic activity is directly proportional to the concentration of active enzyme, $[E]_{\\text{active}}$.\n\nA reduction in activity by $0.750$ implies the remaining active fraction is\n$$\nf_{\\text{active}} = 1 - 0.750 = 0.250.\n$$\nThus,\n$$\n[E]_{\\text{active}} = f_{\\text{active}} [E]_{\\text{tot}} = 0.250 \\times 20.0 \\text{ nM} = 5.00 \\text{ nM}.\n$$\nRounded to three significant figures, the effective concentration of the remaining active enzyme is $5.00 \\text{ nM}$.", "answer": "$$\\boxed{5.00}$$", "id": "2054780"}, {"introduction": "Beyond understanding the extent of inhibition, it is crucial to know how quickly it occurs. The rate of inactivation is a key parameter in pharmacology, determining how fast a drug takes effect. This practice problem [@problem_id:2054717] explores the first-order kinetics of this process, allowing you to calculate the enzyme's half-life under inhibition, an intuitive measure of the inhibitor's speed.", "problem": "A team of pharmacologists is developing a new covalent inhibitor to target a specific kinase enzyme implicated in a disease pathway. In an in-vitro experiment, they incubate a solution of the purified kinase with a high, saturating concentration of the inhibitor. Under these conditions, the inactivation of the enzyme is found to proceed as a first-order process with respect to the concentration of active enzyme. The progress of the reaction is monitored over time, and the observed first-order rate constant for the inactivation, $k_{obs}$, is determined to be $0.20 \\text{ min}^{-1}$. Calculate the time required for the total activity of the enzyme in the sample to decrease to half of its initial value.\n\nExpress your answer in minutes, rounded to three significant figures.", "solution": "The inactivation follows first-order kinetics with respect to active enzyme concentration. Let $A(t)$ denote the active enzyme activity at time $t$, with initial activity $A(0)=A_{0}$. For first-order decay, the rate law is\n$$\n\\frac{dA(t)}{dt}=-k_{obs}A(t).\n$$\nSeparating variables and integrating from $0$ to $t$ and from $A_{0}$ to $A(t)$ gives\n$$\n\\int_{A_{0}}^{A(t)} \\frac{dA}{A}=-\\int_{0}^{t} k_{obs}\\, dt,\n$$\nwhich yields\n$$\n\\ln\\!\\left(\\frac{A(t)}{A_{0}}\\right)=-k_{obs} t.\n$$\nExponentiating both sides gives\n$$\nA(t)=A_{0}\\exp(-k_{obs} t).\n$$\nThe half-life $t_{1/2}$ is defined by $A(t_{1/2})=\\frac{A_{0}}{2}$. Substituting,\n$$\n\\frac{A_{0}}{2}=A_{0}\\exp(-k_{obs} t_{1/2}) \\quad \\Rightarrow \\quad \\frac{1}{2}=\\exp(-k_{obs} t_{1/2}).\n$$\nTaking the natural logarithm,\n$$\n\\ln\\!\\left(\\frac{1}{2}\\right)=-k_{obs} t_{1/2} \\quad \\Rightarrow \\quad t_{1/2}=\\frac{\\ln(2)}{k_{obs}}.\n$$\nWith $k_{obs}=0.20 \\text{ min}^{-1}$,\n$$\nt_{1/2}=\\frac{\\ln(2)}{0.20} \\text{ min}\\approx \\frac{0.693147}{0.20} \\text{ min}\\approx 3.47 \\text{ min},\n$$\nrounded to three significant figures.", "answer": "$$\\boxed{3.47}$$", "id": "2054717"}, {"introduction": "In drug development, scientists often need to compare the effectiveness of different inhibitor candidates. Is a compound that binds tightly but reacts slowly better than one that binds weakly but reacts quickly? This problem [@problem_id:2054749] delves into this question by introducing inhibitor efficiency, a crucial metric calculated from the ratio $\\frac{k_{\\text{inact}}}{K_I}$ that allows for a direct comparison of overall inhibitor potency.", "problem": "A team of biochemists is developing a drug to target a critical enzyme, \"virulence-associated protease\" (VAP), from a pathogenic bacterium. They have synthesized two promising compounds, Compound Alpha and Compound Beta, both of which act as time-dependent, irreversible inhibitors of VAP. The mechanism of inhibition involves the initial non-covalent formation of an enzyme-inhibitor complex (EI), followed by a slower covalent modification step that permanently inactivates the enzyme.\n\nThe kinetic parameters for these two inhibitors were determined experimentally:\n\n*   **Compound Alpha:** The dissociation constant for the initial non-covalent binding is $K_I = 15.0 \\ \\mu\\text{M}$, and the maximal rate constant for inactivation is $k_{inact} = 0.600 \\ \\text{s}^{-1}$.\n*   **Compound Beta:** The dissociation constant is $K_I = 120.0 \\ \\mu\\text{M}$, and the maximal rate constant for inactivation is $k_{inact} = 4.20 \\ \\text{s}^{-1}$.\n\nTo compare the overall potency of these two compounds, especially under conditions where the inhibitor concentration is low (i.e., $[I] \\ll K_I$), the team needs to determine their relative efficiencies. Calculate the ratio of the efficiency of the more potent inhibitor to that of the less potent inhibitor. Round your final answer to three significant figures.", "solution": "For a two-step irreversible inhibitor, $E + I \\rightleftharpoons EI \\xrightarrow{k_{inact}} E-I'$, the observed first-order inactivation rate at inhibitor concentration $[I]$ is\n$$\nk_{obs} = \\frac{k_{inact}[I]}{K_{I} + [I]}.\n$$\nWhen $[I] \\ll K_{I}$, we approximate $K_{I} + [I] \\approx K_{I}$, giving\n$$\nk_{obs} \\approx \\left(\\frac{k_{inact}}{K_{I}}\\right)[I].\n$$\nThus, the efficiency (second-order rate constant under low $[I]$) is\n$$\n\\eta = \\frac{k_{inact}}{K_{I}}.\n$$\n\nCompute efficiencies for each compound:\n$$\n\\eta_{\\text{Alpha}} = \\frac{0.600}{15.0} = 0.0400, \\qquad\n\\eta_{\\text{Beta}} = \\frac{4.20}{120.0} = 0.0350.\n$$\nAlpha is more potent since $0.0400 > 0.0350$. The ratio of the efficiency of the more potent to the less potent is\n$$\nR = \\frac{\\eta_{\\text{Alpha}}}{\\eta_{\\text{Beta}}}\n= \\frac{\\frac{0.600}{15.0}}{\\frac{4.20}{120.0}}\n= \\frac{0.600 \\times 120.0}{15.0 \\times 4.20}\n= \\frac{72.0}{63.0}\n= 1.142857\\ldots\n$$\nRounded to three significant figures,\n$$\nR = 1.14.\n$$", "answer": "$$\\boxed{1.14}$$", "id": "2054749"}]}